Connection

Karine Lacombe to Spike Glycoprotein, Coronavirus

Back to Details
This is a "connection" page, showing publications Karine Lacombe has written about Spike Glycoprotein, Coronavirus.
Karine Lacombe
Connection Strength
0.006
Spike Glycoprotein, Coronavirus
  1. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial. Trials. 2021 Mar 09; 22(1):199.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.